Lonza Completes Expansion of Conjugation Facility

Lonza (Basel, Switzerland) has announced that a planned expansion of its bioconjugation facility in Visp, Switzerland is complete. The expansion includes two manufacturing suites and supporting infrastructure. It will support an extended customer portfolio, including companies entering clinical development. The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and will play a ...